cupure logo
trumpiranwardeathcourtpolicerevealstrumpswatchwoman

Alzheimer´s drugs rejected for NHS because benefits...

The National Institute for Health and Care Excellence is standing by its earlier decision to turn down donanemab and lecanemab after considering new information.

Comments

Similar News

Breaking news